Mia's Feed
Medical News & Research

New Metabolic Target Offers Hope for Treating Rare and Aggressive Childhood Cancer

New Metabolic Target Offers Hope for Treating Rare and Aggressive Childhood Cancer

Share this article

Researchers from the University of Iowa have identified a critical metabolic pathway in an aggressive childhood cancer, opening new horizons for targeted therapies and improved patient outcomes.

2 min read

A groundbreaking study has uncovered a vital metabolic vulnerability in Malignant Peripheral Nerve Sheath Tumor (MPNST), a rare and highly aggressive childhood cancer predominantly affecting teenagers and young adults. This form of cancer is characterized by rapid growth and a tendency to spread, with limited effective treatment options, especially once it metastasizes. Currently, there are no targeted therapies available for metastatic MPNST, making new treatment approaches critically important.

Researchers from the University of Iowa, led by Dr. Eric Taylor and Dr. Rebecca Dodd, employed advanced gene editing techniques to develop models that accurately replicate the genetic mutations found in patients. Using these models, they utilized cutting-edge genomic and metabolomic analyses to investigate the cancer’s fuel sources. Their findings, published in Science Advances, revealed that MPNST cells depend heavily on a specific metabolic pathway to survive oxidative stress and sustain tumor growth.

The study identified the Pentose Phosphate Pathway (PPP) as a key process in these tumor cells. This pathway metabolizes sugars to generate molecules essential for combatting oxidative damage. When researchers inhibited the PPP, the tumors grew more slowly and became more susceptible to chemotherapy, indicating a promising therapeutic target.

This discovery is significant because it links the PPP pathway directly to MPNST tumor progression for the first time, opening new avenues for treatment development. The collaborative research combined expertise in cancer biology and metabolism, led by graduate student Gavin McGivney, now a postdoctoral researcher at the University of Chicago.

Dodd emphasizes that targeting the PPP could lead to novel strategies to slow tumor growth and improve patient outcomes in this difficult-to-treat cancer. The findings suggest that future therapies might incorporate metabolism-based approaches to enhance current treatments. This research marks a vital step toward more effective interventions for children and young adults affected by MPNST.

Source: https://medicalxpress.com/news/2025-08-metabolic-pathway-rare-aggressive-childhood.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Enhancing Incentives in Contingency Management Can Boost Addiction Recovery Success

Recent studies suggest that increasing incentives in contingency management programs can significantly improve recovery outcomes for individuals battling opioid and stimulant addiction, supporting more effective treatment strategies.

The Spread of Red Meat Allergy Triggered by Tick Bites and the Role of Different Ticks in Alpha-Gal Syndrome

Alpha-gal syndrome is an increasingly common allergy triggered by tick bites, causing severe reactions to red meat and other mammalian products. This global spread involves multiple tick species, not just the lone star tick. Awareness and prevention are key to managing this emerging health concern.

Advancements in MRI Correction Techniques Enhance Brain Structure Insights in Children with ADHD

Innovative MRI correction techniques like the traveling-subject method are improving the understanding of brain structural differences in children with ADHD, offering potential for earlier diagnosis and personalized treatments.

Innovative Imaging Technology Tracks Brain Waves to Enhance Disease Research and AI Development

Stanford researchers have developed advanced optical devices to visualize brain waves in unprecedented detail, offering new insights into neural activity, disease mechanisms, and AI development.